<DOC>
	<DOCNO>NCT00906308</DOCNO>
	<brief_summary>This phase 3a study design ass safety efficacy MF101 frequency moderate severe hot flush postmenopausal woman .</brief_summary>
	<brief_title>A Study MF101 Postmenopausal Women</brief_title>
	<detailed_description>Menopausal woman often experience debilitate menopausal vasomotor symptom associate insomnia . Until recently , vasomotor symptom often treat estrogen , effective ; however , randomize clinical trial show postmenopausal combination hormone therapy increase risk stroke , cardiovascular event , breast cancer . New , effective , safe treatment menopausal vasomotor symptom therefore need . MF101 , botanical extract , non-hormonal investigational treatment test randomized , double-blind , placebo-controlled phase 3a clinical trial ass safety efficacy MF101 frequency moderate severe hot flush postmenopausal woman . Approximately 1200 healthy post-menopausal woman , age 40-65 , moderate severe hot flush enrol determine safety efficacy two dos MF101 ( 5 g/day 10 g/day ) compare placebo 12 week treatment .</detailed_description>
	<mesh_term>Hot Flashes</mesh_term>
	<criteria>Inclusion Criteria ( limit ) : Confirmed postmenopausal woman age 4065 Provide write informed consent Exclusion Criteria ( limit ) : History malignancy , exception certain type skin cancer cervical cancer Known carrier BRCA1 BRCA2 Abnormal mammogram breast examination suggestive cancer within 9 month screen Endometrial hyperplasia , polyp abnormal uterine mass ( exception fibroid ) Clinical evidence active ischemic heart disease , history cardiovascular disease , uncontrolled hypertension , history transient ischemic attack cerebrovascular accident History deep vein thrombosis , pulmonary embolism , severe chronic diarrhea , chronic constipation , uncontrolled inflammatory bowel syndrome disease ( IBS IBD ) , unexplained weight loss Active liver disease gall bladder disease History chronic hepatitis B , hepatitis C , hepatitis within 3 month , HIV infection Use prescription medication herbal/dietary supplement treatment hot flush know estrogenic/progestogenic activity within require washout timeframes Use selective receptor modulators ( SERMs ) , aromatase inhibitor , gonadotropinreleasing hormone agonist , selective serotonin reuptake inhibitor ( SSRIs ) , selective norepinephrine reuptake inhibitor ( SNRIs ) , gabapentin clonidine within require washout timeframes Chronic use morphine opiate</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>